Company Overview

ConcertAI is a leader in Generative AI technology solutions for life sciences, healthcare, and oncology Real-World Evidence solutions. Our mission is to accelerate insights and outcomes for patients through leading data, AI technologies, and scientific expertise in partnership with the leading biomedical innovators, healthcare providers, and medical societies. Serving over 1,900 clinical sites and 45 biomedical innovators, ConcertAI’s companies and solutions are Best in KLAS, awarded in 2020, 2021, and 2022. Headquartered in Cambridge, MA, ConcertAI has offices in Philadelphia, Frankfurt, Raleigh-Durham, and Tokyo. For more information, visit us at


Contact Details:

PR/Media Contact

Megan Duero,



ConcertAI CEO – Jeff Elton, PhD

Jeff Elton, Ph.D., is the founding CEO of ConcertAI, a leader in enterprise Generative and Predictive AI for life sciences and healthcare; SaaS Solutions for clinical development, advanced oncology insights, and clinical interpretation; and the largest multimodal, ‘AI ready,’ oncology data-as-a-service for life sciences and healthcare research. Prior to ConcertAI, Jeff was a Managing Director at Accenture Strategy/Patient Health; Senior Vice President of Strategy and Global Chief Operating Officer at Novartis Institutes for BioMedical Research, Inc.; and a partner at McKinsey & Company. He is the co-author of the widely cited book ‘Healthcare Disrupted’ (Wiley, 2016), numerous articles, widely read perspectives, and The ConcertAI Podcast. Jeff holds a Ph.D. and an M.B.A. from The University of Chicago.

ConcertAI CEO – Jeff Elton, PhD